ロード中...
The use of ancrod to prevent thrombosis on prosthetic heart valves
Ancrod (Arvin) on slow intravenous administration converts fibrinogen into fibrin at a rate which does not cause intravascular thrombosis. The fibrin is eliminated from the circulation and the blood is thus rendered incoagulable. To test the efficacy of ancrod in the prevention of thrombosis after p...
保存先:
| 出版年: | Thorax |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
1970
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC472177/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/5485009/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.25.4.472 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|